# Researcher Response — Iteration 1

STATUS: CONTINUE

## Deliberation

The reviewer has ACCEPTED the paper and flagged five polish items. All are reasonable and implementable. Brief deliberation on each:

1. **Add explicit in-sample caveat ("The One Big Thing")**
   - Agree: This is the most predictable criticism from quantitative readers and we should preempt it.
   - Feasible: Yes — one paragraph in the Methodology section.
   - Impact: Medium-high. Prevents the most obvious objection.
   - Action: Added "In-Sample Caveat" subsection in Methodology, before Statistical Corrections.

2. **SPX comparison frequency labels**
   - Agree: The table invites direct numerical comparison between hourly and daily measurements. Labels prevent casual conflation.
   - Feasible: Yes — parenthetical additions to table cells.
   - Impact: Medium. Small change but prevents misreading.
   - Action: Added "(hourly)" and "(daily)" labels to the violation rate row in the no-arbitrage table.

3. **Section 4 bridge sentence**
   - Agree: Section 4 does feel orphaned from the main CRPS narrative. A single connecting sentence improves coherence.
   - Feasible: Yes — one sentence.
   - Impact: Medium. Structural improvement to narrative flow.
   - Action: Added bridge sentence at the top of Section 4 connecting maturity analysis to the series-level calibration heterogeneity in Section 2.

4. **Mechanism 3 qualifier (trader composition)**
   - Agree: Mechanisms 1, 2, and 4 have testable predictions; mechanism 3 does not with public data. It should be flagged as speculative.
   - Feasible: Yes — parenthetical qualifier.
   - Impact: Low-medium. Intellectual honesty about what's falsifiable.
   - Action: Added *(speculative — not directly testable with public data)* qualifier to mechanism 3.

5. **CRPS tail decomposition note**
   - Agree: This would sharpen the mechanism discussion and signals methodological awareness. As a future work note, it's appropriate.
   - Feasible: Yes — one sentence added to the mechanism discussion.
   - Impact: Medium. Points toward the natural next analysis.
   - Action: Added sentence at the end of the mechanism paragraph noting that future work should decompose CRPS by quantile region to distinguish tail vs. center mispricing.

## Changes Made

1. **Methodology section**: Added "In-Sample Caveat" subsection explicitly stating all results use the full dataset, train/test splitting is impractical at n=14–16, and out-of-sample validation is a priority as data accumulates.
2. **Section 1, No-Arbitrage table**: Added "(hourly)" and "(daily)" frequency labels to the violation rate row to prevent conflation of measurement frequencies.
3. **Section 4 opening**: Added bridge sentence connecting market maturity analysis to the series-level calibration heterogeneity from Section 2.
4. **Section 2, Mechanism 3**: Added *(speculative — not directly testable with public data)* qualifier to the trader composition hypothesis.
5. **Section 2, Mechanism paragraph**: Added future work sentence on CRPS quantile decomposition to distinguish tail vs. center mispricing (relevant to mechanism 4).
6. **Status line**: Updated to reflect iteration 7 and the polish changes.

## Pushbacks

None. All five suggestions are reasonable, low-risk, and improve the paper without changing any claims or introducing new risks. The reviewer's judgment is sound on these polish items.

## Remaining Weaknesses

- **Two-series comparison**: The frequency hypothesis still rests on a single CPI vs. Jobless Claims contrast. This is inherent to the data window.
- **No order book data**: Cannot directly test mechanism 4 (liquidity at extreme strikes). The new tail decomposition note acknowledges this as future work.
- **Small n throughout**: 14–16 events per series limits statistical power for all but the largest effects. The in-sample caveat now makes this explicit.

## Convergence Assessment

The paper was already in strong shape before this polish pass. The five changes are all minor improvements — none changes the substance, claims, or methodology. The reviewer scored the paper 7-8/10 across all criteria and issued an ACCEPT. After this iteration, I believe the paper is at diminishing returns. One more review cycle to confirm convergence, then we should publish.
